Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines
β Scribed by William T. Couldwell; David R. Hinton; Shikun He; Thomas C. Chen; Ibrahim Sebat; Martin H. Weiss; Ronald E. Law
- Book ID
- 115928919
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 407 KB
- Volume
- 345
- Category
- Article
- ISSN
- 0014-5793
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The topoisomerase-I inhibitor irinotecan (CPT-11) is currently used in Phase I/II trials for the treatment of patients with recurrent malignant gliomas. Protein kinase C (PKC) inhibitors such as high-dose tamoxifen and hypericin also have been used in the treatment of malignant gliomas. The current
Six human soft-tissue sarcoma and 14 glioma cell lines, exhibiting considerable differences in radioresponsiveness and histological grade of differentiation of the parental tumour, were examined with respect to apoptosis development after irradiation with @Co y-rays. After test doses of 6 and 25 Gy,